Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
30,428,990
-
Shares change
-
+695,019
-
Total reported value, excl. options
-
$832,590,372
-
Value change
-
+$19,372,010
-
Put/Call ratio
-
19.66%
-
Number of buys
-
97
-
Number of sells
-
-68
-
Price
-
$27.36
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2016
210 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2016.
REPLIGEN CORP - COMMON STOCK (RGEN) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,428,990 shares
of 56,222,082 outstanding shares and own 54.12% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (2,551,928 shares), OppenheimerFunds, Inc. (1,893,624 shares), Invesco Ltd. (1,815,025 shares), VANGUARD GROUP INC (1,565,708 shares), FMR LLC (1,523,873 shares), RENAISSANCE TECHNOLOGIES LLC (1,124,804 shares), Conestoga Capital Advisors, LLC (1,057,588 shares), DIMENSIONAL FUND ADVISORS LP (1,046,474 shares), STATE STREET CORP (943,738 shares), and BlackRock Institutional Trust Company, N.A. (899,594 shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.